GlassScriptPhysician profile
Meghan Galli
NPI 1053945204
$3,290.15
in general payments reported to CMS, 2019-2025
29 companies · $521 in 2025
The $521 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $509 · 2022: $925 · 2023: $594 · 2024: $741 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,767 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,766.91 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $777.34 | 2021-2025 | Veozah, Myrbetriq |
| Axonics, INC. | $530.87 | 2021-2024 | Axonics |
| Coloplast Corp | $322.72 | 2021-2025 | Speedicath, Saffron |
| Pfizer INC. | $310.67 | 2021-2025 | |
| Antares Pharma, INC. | $206.83 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $175.19 | 2023-2025 | Orgovyx, Gemtesa |
| Urovant Sciences INC | $139.08 | 2022 | |
| Myovant Sciences INC. | $99.86 | 2022 | |
| Myriad Genetic Laboratories, INC. | $93.64 | 2023-2024 | Prolaris |
| Boston Scientific Corporation | $77.06 | 2022-2024 | Upsylon, Solyx Sis System |
| Abbvie INC. | $63.66 | 2023-2025 | |
| 180 Medical, INC. | $62.24 | 2021-2022 | |
| Halozyme INC | $57.55 | 2023 | |
| Dentsply Ih Ab | $36.36 | 2023 | Lofric |
| Ferring Pharmaceuticals INC. | $36.29 | 2024 | Adstiladrin |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $28.60 | 2023 | Itind System |
| Glaxosmithkline, LLC. | $28.43 | 2024-2025 | Nucala |
| Hollister Incorporated | $27.65 | 2021-2023 | Vapro Pocket |
| Dentsply Ih INC. | $27.38 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $24.25 | 2022 | |
| Tempus Ai, INC | $23.75 | 2024 | Xt Cdx |
| Merck Sharp & Dohme LLC | $21.57 | 2024 | Keytruda |
| Calyxo, INC. | $20.89 | 2025 | Cvac Aspiration System |
| Millicent US INC | $19.47 | 2024 | Intrarosa, Femring |
| Abc Home Medical Supply, INC. | $18.39 | 2024 | |
| Medtronic, INC. | $17.27 | 2022 | |
| Agiliti Surgical, INC. | $15.37 | 2025 | Coloplast Tfl Drive Laser, Omniguide Revolix Thulium Laser (30, 120, 200w), Boston Scientific Lumenis Pulse 120h Holmium Laser W/ Moses Technology |
| Mission Pharmacal Company | $15.35 | 2022 | |
| Integra Lifesciences Corporation | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Galli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.